Tomer Kariv

Director, Arno Therapeutics, Inc.

Companies

Keros Therapeutics, Inc.Board member Apr 7, 2020 to now¹
Eloxx Pharmaceuticals, Inc.Board member Dec 29, 2017 to Jan 31, 2023²
LogicBio Therapeutics, Inc.Board member Oct 18, 2018 to Dec 20, 2019³
89bio, Inc.Board member Nov 8, 2019 to Nov 13, 2019⁴
VBI Vaccines Inc/BCBoard member Jan 29, 2018 to Feb 4, 2019⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Keros Therapeutics, Inc. KROS160,512 shares⁶$1.8M at $11.04Jun 11, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 4, 2025Granted 5,250 shares of Keros Therapeutics, Inc.⁷
Nov 29, 2022Exercised 1,914 shares of Keros Therapeutics, Inc.⁸
Nov 29, 2022Exercised 1,723 shares of Keros Therapeutics, Inc.⁸
Nov 29, 2022Exercised 3,539 shares of Keros Therapeutics, Inc.⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARKeros Therapeutics, Inc., Board member
2
SEC EDGAREloxx Pharmaceuticals, Inc., Board member
3
SEC EDGARLogicBio Therapeutics, Inc., Board member
4
SEC EDGAR89bio, Inc., Board member
5
SEC EDGARVBI Vaccines Inc/BC, Board member
6
SEC EDGARKeros Therapeutics, Inc. shares after the filing of Jun 11, 2025
7
SEC EDGARForm 4 filed Jun 6, 2025
8
SEC EDGARForm 4 filed Nov 30, 2022